A Phase 2 Study of Magrolimab Combination Therapy in Patients with Recurrent or Metastatic Head and Neck Squamous-Cell Carcinoma Colevas, A. D., Park, J. J., Fang, B., Shao, J., U'Ren, L., Odegard, J., Lal, I., Phan, M., Thein, K. Z., Adkins, D. ELSEVIER SCIENCE INC. 2022: E42-E43

View details for Web of Science ID 000769937700087